Skip to main content Skip to section navigation Skip to footer
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on Linkedin
Kintara Therapeutics, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaboration
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News & Events
    • Company Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies

January 25, 2013 • 12:50 PM EST

Del Mar Pharmaceuticals to Present at 5th Annual Biotech Showcase

January 4, 2013 • 12:00 AM EST

DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting

November 15, 2012 • 12:00 AM EST

DelMar CEO Delivers Keynote Address at International Drug Discovery Science and Technology Conference

November 8, 2012 • 12:00 AM EST

DelMar Pharmaceuticals Expands Collaboration with Guangxi Wuzhou Pharmaceutical Company

October 29, 2012 • 12:00 AM EDT

DelMar Pharmaceuticals Named to the “Ready to Rocket” List for the Second Year in a Row

February 28, 2012 • 12:00 AM EST

DelMar Pharmaceuticals to Present New Pre-clinical Data Related to the Mechanism of VAL-083 at the AACR Annual Meeting in April 2012

February 7, 2012 • 12:00 AM EST

DelMar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of Glioma

February 2, 2012 • 12:00 AM EST

DelMar Pharmaceuticals Initiates Glioblastoma Clinical Trial

October 25, 2011 • 12:00 AM EDT

DelMar Pharmaceuticals Receives FDA IND Approval to Begin Clinical Trials with a New Brain Cancer Treatment

September 6, 2011 • 12:00 AM EDT
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Next Pagearrow_forward
rss_feed News RSS
©2023 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences